Cart
sales@molnova.com
Tafetinib
CAS No. 1032265-57-8
Tafetinib( —— )
Catalog No. M34438 CAS No. 1032265-57-8
Tafetinib (SIM-010603) is a novel potent and orally available tyrosine kinase inhibitor with anti-angiogenic and anti-tumour activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 380 | Get Quote |
|
| 5MG | 592 | Get Quote |
|
| 10MG | 843 | Get Quote |
|
| 25MG | 1224 | Get Quote |
|
| 50MG | 1638 | Get Quote |
|
| 100MG | 2187 | Get Quote |
|
| 500MG | 4392 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameTafetinib
-
NoteResearch use only, not for human use.
-
Brief DescriptionTafetinib (SIM-010603) is a novel potent and orally available tyrosine kinase inhibitor with anti-angiogenic and anti-tumour activity.
-
DescriptionTafetinib (SIM010603) is an oral multi-targets receptor tyrosine kinases inhibitor. Tafetinib inhibitsstem cell factor receptor (Kit),vascular endothelial growth factor receptor-2 (VEGFR-2),platelet-derived growth factor receptor-β (PDGFR-β),glial cell line-derived neurotrophic factor receptor (Rearranged during Transfection; RET), andFms-like tyrosine kinase-3 (FLT3)withIC50values between 5.0 and 68.1 nmol/l. Tafetinib inhibits the phosphorylation ofPDGFR-βandVEGFR-2. Tafetinib inhibits endothelial cell proliferation, endothelial cells chemotaxis, and corneal angiogenesis.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayProteasome/Ubiquitin
-
TargetTyrosinase
-
RecptorTyrosine Kinases
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1032265-57-8
-
Formula Weight424.51
-
Molecular FormulaC24H29FN4O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1/C(=C/2\C3=C(C(C(NCCN(CC)CC)=O)=C(C)N3)CCC2)/C=4C(N1)=CC=C(F)C4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Wang D, et al. Preclinical anti-angiogenesis and anti-tumor activity of SIM010603, an oral, multi-targets receptor tyrosine kinases inhibitor. Cancer Chemother Pharmacol. 2012;69(1):173-183.?
molnova catalog
related products
-
NDI-034858
NDI-034858 (TAK-279) is a tyrosine kinase 2 (TYK2) inhibitor (Kd<200 pM) that targets the JH2 structural domain of Tyk2 for the treatment of autoimmune diseases caused by aberrant expression of IL12 and IL23.
-
hTYR/AbTYR-IN-1
hTYR/AbTYR-IN-1 is a dual hTYR/AbTYR inhibitor with inhibitory effects on hTYR and AbTYR, with IC50s of 5.4 μM and 3.52 μM, respectively.
-
AMG 925
AMG 925 is a potent and orally bioavailable dual FLT3/CDK4 inhibitor with IC50 of 1 nM and 3 nM, respectively.
